Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2004 1
2005 2
2006 3
2007 3
2008 3
2009 3
2011 1
2012 3
2013 3
2014 1
2015 3
2016 4
2017 2
2018 4
2019 7
2020 6
2021 10
2022 15
2023 11
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

85 results

Results by year

Filters applied: . Clear all
Page 1
Additive efficacy of a bispecific anti-TNF/IL-6 nanobody compound in translational models of rheumatoid arthritis.
Biesemann N, Margerie D, Asbrand C, Rehberg M, Savova V, Agueusop I, Klemmer D, Ding-Pfennigdorff D, Schwahn U, Dudek M, Heyninck K, De Tavernier E, Cornelis S, Kohlmann M, Nestle FO, Herrmann M. Biesemann N, et al. Among authors: herrmann m. Sci Transl Med. 2023 Feb;15(681):eabq4419. doi: 10.1126/scitranslmed.abq4419. Epub 2023 Feb 1. Sci Transl Med. 2023. PMID: 36724239
An orally available small molecule that targets soluble TNF to deliver anti-TNF biologic-like efficacy in rheumatoid arthritis.
Vugler A, O'Connell J, Nguyen MA, Weitz D, Leeuw T, Hickford E, Verbitsky A, Ying X, Rehberg M, Carrington B, Merriman M, Moss A, Nicholas JM, Stanley P, Wright S, Bourne T, Foricher Y, Brookings D, Horsley H, Herrmann M, Rao S, Kohlmann M, Florian P. Vugler A, et al. Among authors: herrmann m. Front Pharmacol. 2022 Nov 16;13:1037983. doi: 10.3389/fphar.2022.1037983. eCollection 2022. Front Pharmacol. 2022. PMID: 36467083 Free PMC article.
Tofacitinib bei Colitis ulcerosa.
Herrmann M. Herrmann M. MMW Fortschr Med. 2022 Jan;164(1):73. doi: 10.1007/s15006-022-0683-8. MMW Fortschr Med. 2022. PMID: 35043347 German. No abstract available.
Vabysmo® - länger schärfer sehen.
Herrmann M. Herrmann M. MMW Fortschr Med. 2023 Sep;165(15):65. doi: 10.1007/s15006-023-2930-z. MMW Fortschr Med. 2023. PMID: 37653329 German. No abstract available.
Ansatz zur Heilung der HIV-Infektion.
Herrmann M. Herrmann M. MMW Fortschr Med. 2023 Jun;165(Suppl 2):50. doi: 10.1007/s15006-023-2710-9. MMW Fortschr Med. 2023. PMID: 37249858 German. No abstract available.
Upstaza™ - Ausgleich von AADC-Mangel.
Herrmann M. Herrmann M. MMW Fortschr Med. 2023 Oct;165(17):66. doi: 10.1007/s15006-023-3022-9. MMW Fortschr Med. 2023. PMID: 37759032 German. No abstract available.
Neutrophilic granulocyte-derived B-cell activating factor supports B cells in skin lesions in hidradenitis suppurativa.
Sabat R, Šimaitė D, Gudjonsson JE, Brembach TC, Witte K, Krause T, Kokolakis G, Bartnik E, Nikolaou C, Rill N, Coulibaly B, Levin C, Herrmann M, Salinas G, Leeuw T, Volk HD, Ghoreschi K, Wolk K. Sabat R, et al. Among authors: herrmann m. J Allergy Clin Immunol. 2023 Apr;151(4):1015-1026. doi: 10.1016/j.jaci.2022.10.034. Epub 2022 Dec 5. J Allergy Clin Immunol. 2023. PMID: 36481267
Gentest kann erbliche Augenerkrankung entlarven.
Herrmann M. Herrmann M. MMW Fortschr Med. 2022 Oct;164(17):74. doi: 10.1007/s15006-022-1955-z. MMW Fortschr Med. 2022. PMID: 36198979 German. No abstract available.
Neuer Antikörper gegen Makuladegeneration.
Herrmann M. Herrmann M. MMW Fortschr Med. 2021 Mar;163(Suppl 1):90. doi: 10.1007/s15006-021-9903-x. MMW Fortschr Med. 2021. PMID: 33950461 German. No abstract available.
85 results